For the quarter ending 2025-09-30, CGABL had $949,500K increase in cash & cash equivalents over the period. -$1,582,700K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 112,500 | 486,700 |
| Depreciation and amortization | 48,500 | 94,600 |
| Equity-based compensation | 90,700 | 196,400 |
| Non-cash performance allocations and incentive fees, net | -263,700 | 250,600 |
| Non-cash principal investment income | 82,800 | -32,600 |
| Other non-cash amounts | 900 | -36,800 |
| Realized/unrealized (gain) loss on investments of consolidated funds | 88,500 | 11,600 |
| Realized/unrealized (gain) loss from loans payable of consolidated funds | 34,700 | 41,300 |
| Purchases of investments by consolidated funds | 4,957,100 | 4,033,200 |
| Proceeds from sales and settlements of investments by consolidated funds | 2,858,200 | 2,311,100 |
| Non-cash interest income, net | 4,300 | 8,700 |
| Change in cash and cash equivalents held at consolidated funds | 88,300 | -405,400 |
| Change in other receivables held at consolidated funds | 18,500 | -10,500 |
| Change in other liabilities held at consolidated funds | 79,300 | -14,000 |
| Purchases of investments | 106,800 | 144,300 |
| Proceeds from the sale of investments | 194,400 | 469,600 |
| Payments of contingent consideration | 1,700 | 1,000 |
| Changes in deferred taxes, net | 51,000 | 16,500 |
| Change in due from affiliates and other receivables | -7,600 | 16,300 |
| Change in deposits and other | 500 | 24,900 |
| Change in accounts payable, accrued expenses and other liabilities | -1,300 | 39,100 |
| Change in accrued compensation and benefits | 54,800 | -116,200 |
| Change in due to affiliates | 1,500 | 23,600 |
| Change in lease right-of-use assets and lease liabilities | -3,400 | -6,300 |
| Change in deferred revenue | 169,100 | 57,600 |
| Net cash used in operating activities | -1,559,500 | -520,900 |
| Purchases of corporate treasury investments | 0 | 0 |
| Proceeds from corporate treasury investments | 0 | - |
| Purchases of fixed assets, net | 23,200 | 34,200 |
| Net cash used in investing activities | -23,200 | -34,200 |
| Borrowings under credit facilities | 0 | 0 |
| Repayments under credit facilities | 0 | 0 |
| Issuance of 5.05 senior notes due 2035, net of financing costs | 792,900 | - |
| Payments on clo borrowings | 11,900 | 40,100 |
| Proceeds from clo borrowings, net of financing costs | 49,700 | 15,100 |
| Net borrowings on loans payable of consolidated funds | 1,700,000 | 1,055,100 |
| Dividends to common stockholders | 126,500 | 252,700 |
| Payment of deferred consideration for carlyle holdings units | 0 | 0 |
| Contributions from non-controlling interest holders | 367,800 | 231,300 |
| Distributions to non-controlling interest holders | 109,700 | 198,400 |
| Common shares repurchased and net share settlement of equity-based awards | 202,700 | 280,100 |
| Change in due to/from affiliates financing activities | -29,000 | 3,400 |
| Net cash provided by financing activities | 2,488,600 | 526,800 |
| Effect of foreign exchange rate changes | 43,600 | 38,700 |
| Increase (decrease) in cash, cash equivalents and restricted cash | 949,500 | 10,400 |
| Cash and cash equivalents at beginning of period | 1,266,500 | - |
| Cash and cash equivalents at end of period | 2,226,400 | - |
Carlyle Group Inc. (CGABL)
Carlyle Group Inc. (CGABL)